Virax Biolabs Group (VRAX) Q3 2025 Earnings
VRAX·Reported December 2, 2025·Before market open
Virax Biolabs Group reported Q3 2025 revenue of $1.6K (-67.5% YoY). Diluted EPS came in at $-0.49 (+44.7% YoY).
Revenue
$1.6K
Diluted EPS
$-0.49
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2025 Earnings FAQ
Common questions about Virax Biolabs Group's Q3 2025 earnings report.
Virax Biolabs Group (VRAX) reported Q3 2025 earnings on December 2, 2025 before market open.
Virax Biolabs Group reported revenue of $1.6K and diluted EPS of $-0.49 for Q3 2025.
Compared to the same quarter a year prior, revenue declined 67.5% from $5.0K a year earlier and diluted EPS grew 44.7% from $-0.89.